Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Crame.

Friday, March 6, 2015, 111 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $7.25 to $35,021,994.00.

Highlighted Stocks Traded by Insiders:

Endo International (ENDP) - FREE Research Report

Lortie Brian, who is President Branded Pharma at Endo International, sold 5,800 shares at $85.35 on March 6, 2015. Following this transaction, the President Branded Pharma owned 16,784 shares meaning that the stake was reduced by 25.68% with the 5,800-share transaction.

The shares most recently traded at $88.27, up $2.92, or 3.31% since the insider transaction. Historical insider transactions for Endo International go as follows:

  • 12-Week # shares bought: 5,478
  • 12-Week # shares sold: 15,592
  • 24-Week # shares bought: 5,478
  • 24-Week # shares sold: 15,592

The average volume for Endo International has been 2.7 million shares per day over the past 30 days. Endo International has a market cap of $15.6 billion and is part of the health care sector and drugs industry. Shares are up 20.67% year-to-date as of the close of trading on Friday.

Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. Currently, there are 11 analysts who rate Endo International a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENDP - FREE

TheStreet Quant Ratings rates Endo International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Endo International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Village Super Market (VLGEA) - FREE Research Report

Estate of Perry Sumas, who is 10% Owner at Village Super Market, sold 13,349 shares at $27.90 on March 6, 2015. Following this transaction, the 10% Owner owned 1.1 million shares meaning that the stake was reduced by 1.2% with the 13,349-share transaction.

The shares most recently traded at $28.40, up $0.50, or 1.75% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 14,578
  • 12-Week # shares sold: 62,911
  • 24-Week # shares sold: 128,744

The average volume for Village Super Market has been 15,300 shares per day over the past 30 days. Village Super Market has a market cap of $275.7 million and is part of the services sector and retail industry. Shares are up 3.87% year-to-date as of the close of trading on Friday.

Village Super Market, Inc., together with its subsidiaries, operates a chain of supermarkets in the United States. The stock currently has a dividend yield of 3.52%. The company has a P/E ratio of 20.0. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings rates Village Super Market as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, impressive record of earnings per share growth and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Village Super Market Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lionbridge Technologies (LIOX) - FREE Research Report

Muir Donald M, who is Chief Financial Officer at Lionbridge Technologies, sold 79,999 shares at $5.82 on March 6, 2015. Following this transaction, the Chief Financial Officer owned 510,600 shares meaning that the stake was reduced by 13.55% with the 79,999-share transaction.

The shares most recently traded at $5.47, down $0.35, or 6.44% since the insider transaction. Historical insider transactions for Lionbridge Technologies go as follows:

  • 4-Week # shares sold: 90,000
  • 12-Week # shares sold: 90,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 120,000

The average volume for Lionbridge Technologies has been 259,900 shares per day over the past 30 days. Lionbridge Technologies has a market cap of $373.1 million and is part of the services sector and diversified services industry. Shares are down 2.09% year-to-date as of the close of trading on Friday.

Lionbridge Technologies, Inc. provides language, content, and testing solutions worldwide. It operates in three segments: Global Language and Content (GLC), Global Enterprise Solutions (GES), and Interpretation. The company has a P/E ratio of 45.0. Currently, there are 4 analysts who rate Lionbridge Technologies a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LIOX - FREE

TheStreet Quant Ratings rates Lionbridge Technologies as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Lionbridge Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null